NDTVCenter·
Novartis, China's Abogen Ink $7.8 Billion Deal For mRNA Therapies
Abogen will receive $575 million upfront, with up to $7.2 billion in milestone payments tied to clinical development, approvals and commercial milestones.
Read at NDTV →
Business · 1 sources covering this
Novartis, China's Abogen Ink $7.8 Billion Deal For mRNA Therapies
Abogen will receive $575 million upfront, with up to $7.2 billion in milestone payments tied to clinical development, approvals and commercial milestones.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/ea46c73dc489266690325cf07be0137875ff6d5a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novartis, China's Abogen Ink $7.8 Billion Deal For mRNA Therapies"></iframe>
